TY - JOUR
T1 - Vitamin E
T2 - The evidence for multiple roles in cancer
AU - Sung, Lillian
AU - Greenberg, Mark L.
AU - Koren, Gideon
AU - Tomlinson, George A.
AU - Tong, Agnes
AU - Malkin, David
AU - Feldman, Brian M.
N1 - Funding Information:
L. Sung is supported by Fellowships from the Canadian Institutes of Health Research (CIHR) Post-Doctoral Program and The Hospital for Sick Children Clinician Scientist Program, M. L. Greenberg holds the POGO Chair in Childhood Cancer Control, G. Koren is a Senior Scientist with CIHR, D. Malkin is a Research Scientist of the National Cancer Institute of Canada/Canadian Cancer Society, and B. M. Feldman holds the Canada Research Chair in childhood arthritis. Address correspondences to David Malkin, Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. Phone: (416) 813-5977. FAX: (416) 813-5327. E-mail: [email protected].
PY - 2003
Y1 - 2003
N2 - There is accumulating evidence that vitamin E may have different roles in the prevention and treatment of cancer. The purpose of this review is to summarize and evaluate this evidence and to suggest future avenues of research. A comprehensive literature review of vitamin E and cancer was conducted. Articles were organized into the following categories: 1) cancer prevention, 2) direct antineoplastic activity, 3) augmentation of chemotherapy effects, and 4) attenuation or treatment of chemotherapy toxicity. The evidence was systematically evaluated using guidelines developed by the U.S. Preventative Services Task Force. There is evidence to suggest that those individuals with higher serum vitamin E levels and those receiving vitamin E supplementation have a decreased risk of some cancers, including lung, prostate, stomach, and gastrointestinal carcinoma. However, these results differed depending on the study design and the population studied. There is insufficient evidence to support anticancer activity and attenuation of chemotherapy toxicity by vitamin E. Vitamin E is likely to be important in the prevention of some cancers. The therapeutic role of vitamin E is poorly understood. Further research will be required before routine use of vitamin E in patients with cancer can be advocated in the clinical setting.
AB - There is accumulating evidence that vitamin E may have different roles in the prevention and treatment of cancer. The purpose of this review is to summarize and evaluate this evidence and to suggest future avenues of research. A comprehensive literature review of vitamin E and cancer was conducted. Articles were organized into the following categories: 1) cancer prevention, 2) direct antineoplastic activity, 3) augmentation of chemotherapy effects, and 4) attenuation or treatment of chemotherapy toxicity. The evidence was systematically evaluated using guidelines developed by the U.S. Preventative Services Task Force. There is evidence to suggest that those individuals with higher serum vitamin E levels and those receiving vitamin E supplementation have a decreased risk of some cancers, including lung, prostate, stomach, and gastrointestinal carcinoma. However, these results differed depending on the study design and the population studied. There is insufficient evidence to support anticancer activity and attenuation of chemotherapy toxicity by vitamin E. Vitamin E is likely to be important in the prevention of some cancers. The therapeutic role of vitamin E is poorly understood. Further research will be required before routine use of vitamin E in patients with cancer can be advocated in the clinical setting.
UR - http://www.scopus.com/inward/record.url?scp=0141848332&partnerID=8YFLogxK
U2 - 10.1207/S15327914NC4601_01
DO - 10.1207/S15327914NC4601_01
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 12925298
AN - SCOPUS:0141848332
SN - 0163-5581
VL - 46
SP - 1
EP - 14
JO - Nutrition and Cancer
JF - Nutrition and Cancer
IS - 1
ER -